• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在澳大利亚建立国家疾病登记处的障碍:从 CHAANZ 先天性心脏病登记处的发展中吸取的教训。

Obstacles in establishing a national disease registry in Australia: lessons from the development of the CHAANZ Congenital Heart Disease Registry.

机构信息

Clinical Research Group, Heart Research Institute, Sydney, NSW, Australia; and Cardiology Department, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW 2050, Australia; and Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.

Cardiology Department, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW 2050, Australia; and Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.

出版信息

Aust Health Rev. 2023 Aug;47(4):410-417. doi: 10.1071/AH23063.

DOI:10.1071/AH23063
PMID:37188545
Abstract

Objectives To provide insights into the obstacles which pose challenges to the set-up of any National Registry in Australia. Methods An analysis of our experience in executing a Multi-Institutional Agreement (MIA) and obtaining ethics and governance approvals, post-award of a large Medical Research Futures Fund grant in June 2020. Results From July 2020, our timeline to an executed MIA was 283 days, despite full-time staff working towards this goal. Subsequently, after lead site ethics approval, time to site governance approvals ranged from 9 to 291 days. A total of 214 emails were sent during the MIA development and signing. There were 11-71 emails sent to individual governance offices and the number of requested points of additional information ranged from 0 to 31 queries. Conclusions There were considerable time delays in executing the initial (pre-research) stages of a National Federal Government funded Registry project which required substantial time and resources. We report a wide variation in requirements between different states and institutions. We propose several strategies which could be implemented to facilitate a more streamlined approach to research ethics and governance. This centralised approach would allow for better use of funding and facilitate better progress in medical research.

摘要

目的 为澳大利亚任何国家登记处的设立所面临的障碍提供深入了解。

方法 分析我们在执行多机构协议(MIA)和获得伦理和治理批准方面的经验,该协议是在 2020 年 6 月获得大型医学研究未来基金拨款后执行的。

结果 自 2020 年 7 月以来,尽管全职员工为此目标而努力,但我们达成执行 MIA 的时间线为 283 天。此后,在主要站点获得伦理批准后,获得站点治理批准的时间范围为 9 至 291 天。在 MIA 的制定和签署过程中总共发送了 214 封电子邮件。向各个治理办公室发送了 11-71 封电子邮件,请求的额外信息点数量从 0 到 31 个查询不等。

结论 在执行联邦政府资助的国家登记处项目的初始(研究前)阶段,需要大量的时间和资源,因此存在相当长的时间延迟。我们报告了不同州和机构之间要求的巨大差异。我们提出了一些可以实施的策略,以促进研究伦理和治理的更简化方法。这种集中的方法将允许更好地利用资金,并促进医学研究的更好进展。

相似文献

1
Obstacles in establishing a national disease registry in Australia: lessons from the development of the CHAANZ Congenital Heart Disease Registry.在澳大利亚建立国家疾病登记处的障碍:从 CHAANZ 先天性心脏病登记处的发展中吸取的教训。
Aust Health Rev. 2023 Aug;47(4):410-417. doi: 10.1071/AH23063.
2
Challenges in obtaining research ethics and governance approvals for an Australian national intersector, multisite audit study.为一项澳大利亚全国性跨部门、多地点审计研究获取研究伦理与管理批准面临的挑战。
Aust Health Rev. 2020 Sep;44(5):799-805. doi: 10.1071/AH20022.
3
Inconsistencies and time delays in site-specific research approvals hinder collaborative clinical research in Australia.澳大利亚特定研究地点审批中的不一致和时间延迟,阻碍了协作性临床研究。
Intern Med J. 2016 Sep;46(9):1023-9. doi: 10.1111/imj.13191.
4
The burdensome logistics of data linkage in Australia - the example of a national registry for congenital heart disease.澳大利亚数据链接的繁琐物流——以国家先天性心脏病登记处为例。
Aust Health Rev. 2024 Feb;48(1):8-15. doi: 10.1071/AH23185.
5
Multi-centre ethics and research governance review can impede non-interventional clinical research.多中心伦理和研究治理审查可能会阻碍非干预性临床研究。
Intern Med J. 2019 Jun;49(6):722-728. doi: 10.1111/imj.14158.
6
Ethics and governance for a multi-site study in Australia: Navigating the snakes and ladders.澳大利亚一项多中心研究的伦理与治理:应对艰难险阻。
J Paediatr Child Health. 2022 Jan;58(1):16-23. doi: 10.1111/jpc.15747. Epub 2021 Sep 16.
7
Addressing the challenges of cross-jurisdictional data linkage between a national clinical quality registry and government-held health data.应对国家临床质量登记处与政府持有的健康数据之间跨辖区数据链接的挑战。
Aust N Z J Public Health. 2016 Oct;40(5):436-442. doi: 10.1111/1753-6405.12576. Epub 2016 Sep 13.
8
Research governance authorisation: the next frontier.研究治理授权:下一个前沿。
Aust Health Rev. 2021 Jun;45(3):389-392. doi: 10.1071/AH20129.
9
Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance.过渡到美国国立卫生研究院单一机构审查委员会模式:试用简化、多地点、加速试验 IRB 资源依赖的方法。
Clin Trials. 2019 Jun;16(3):290-296. doi: 10.1177/1740774519832911. Epub 2019 Mar 13.
10
Multi-centre research in Australia: analysis of a recent National Health and Medical Research Council-funded project.澳大利亚的多中心研究:对近期一项由国家卫生与医学研究委员会资助项目的分析
Respirology. 2009 Sep;14(7):1051-5. doi: 10.1111/j.1440-1843.2009.01595.x.

引用本文的文献

1
Lessons learned from setting up a hospital-based national registry for venous thromboembolic disorders in India.在印度建立基于医院的静脉血栓栓塞症国家登记处的经验教训。
J Family Med Prim Care. 2024 Nov;13(11):4901-4909. doi: 10.4103/jfmpc.jfmpc_264_24. Epub 2024 Nov 18.